ZIM
MTEM

Zacks Investment Management’s Molecular Templates, Inc. MTEM Stock Holding History

Zacks Investment Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,447
Closed -$307K – 602
2019
Q2 		$307K Buy
+2,447
New +$266K 0.01% 486

Other funds holding MTEM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Zacks Investment Management's MTEM Position: Q3 2019 in Review

Zacks Investment Management sold out of Molecular Templates, Inc. (MTEM) in Q3 2019, closing a stake of 2,447 shares — an estimated $307K sold.

Zacks Investment Management first reported a position in MTEM in Q2 2019 and held it in 1 quarter. The position peaked at $307K in Q2 2019. 67 funds tracked by Wall St. Rank hold MTEM as of Q3 2019.

  • Zacks Investment Management reported no remaining Molecular Templates, Inc. position as of Q3 2019 after selling out during the quarter.
  • Zacks Investment Management sold 2,447 Molecular Templates, Inc. shares in Q3 2019, an estimated $307K.
  • Zacks Investment Management first reported a position in Molecular Templates, Inc. in Q2 2019 and held it in 1 quarter.
  • Zacks Investment Management's Molecular Templates, Inc. position peaked at $307K in Q2 2019.
  • 67 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2019.

Based on Zacks Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.